3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
OTHER
2
INDUSTRY
2
NIH
1
Study Type
Interventional
4
Observational
1
Sponsor
Conditions
Metabolic Syndrome
1
Inflammation
1
Hypogonadism
1
Diabetes Mellitus
1
Interventions
Amplified Fragment Length Polymorphism Analysis
21
Gene Expression Profiling
17
Microarray Analysis
13
Immunohistochemistry
12
Polymerase Chain Reaction
9
Specimen Handling
6
Psychiatric Rehabilitation
6
Reverse Transcriptase Polymerase Chain Reaction
5
Mass Spectrometry
4
Flow Cytometry
4
Biopsy
4
Molecular Diagnostic Techniques
3
Mental Status and Dementia Tests
3
Magnetic Resonance Spectroscopy
3
Immunologic Techniques
3
Genetic Linkage
3
DNA Methylation
3
Cytogenetic Analysis
3
Chromatography, High Pressure Liquid
3
Watchful Waiting
2
Therapeutics
2
Leukapheresis
2
In Situ Hybridization, Fluorescence
2
Immunoenzyme Techniques
2
Genetic Testing
2
Early Intervention, Educational
2
Cyclophosphamide
2
Carboplatin
2
Bleeding Time
2
hepatitis B hyperimmune globulin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NIH
×
Observational
×
Pioglitazone
×
Clear all
NCT00743327
2012-08-06
ADT
National Institutes of Health Clinical Center (CC)
Terminated
1 enrolled